864-3 Transendocardial autologous bone marrow cell transplantation in patients with advanced ischemic heart disease: Final results from a multi-center feasibility study

Josep M. Llovet, Thomas Decaens, Jean‐Luc Raoul, Éveline Boucher, Masatoshi Kudo, Cheng‐Chen Chang, Yang Kang, Éric Assenat, Ho-Yeong Lim, Valérie Boige, Philippe Mathurin, Lætitia Fartoux, Derek Lin, Jordi Bruix, Rtp Poon, Morris Sherman, J.-F. Blanc, Richard S. Finn, Won Young Tak, You‐Chen Chao, Rana Ezzeddine, D. Liu, Ian Walters, J.-W. Park

Journal of Hepatology

Article2002

Improved outcome with longer radiation sources: final results of the RENO registry in 1098 patients

Sigmund Silber, Dietrich Baumgart, Antonio Colombo, Patrick W. Serruys, David Meerkin, Thomas M. Schiele, R. C. Dorr, Klaus Kleinertz, We. Auch-Schwelck, William Wijns, Éric Eeckhout, Philip Urban

Journal of the American College of Cardiology

Article2004

Fluvastatin Reduces Cardiac Mortality in Patients with Coronary Heart Disease

Christie M. Ballantyne, Günter A.J. Riegger, Nicholas Moore, Francesco Saia, Patrick W. Serruys

Cardiovascular Drugs and Therapy

Article1984

Haemodynamic effects of intravenous cibenzoline in patients with coronary heart disease

Marcel van den Brand, Patrick W. Serruys, Y. de Roon, Marie France Aymard, A Dufour

European Journal of Clinical Pharmacology

864-3 Transendocardial autologous bone marrow cell transplantation in patients with advanced ischemic heart disease: Final results from a multi-center feasibility study

Abstract

Discussion(0)

Related publications

Cigarette smoking increases the release of prostacyclin into the coronary circulation in patients with ischemic heart disease

1398 BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY

Improved outcome with longer radiation sources: final results of the RENO registry in 1098 patients

Fluvastatin Reduces Cardiac Mortality in Patients with Coronary Heart Disease

Haemodynamic effects of intravenous cibenzoline in patients with coronary heart disease